Key result
pRVAD successfully supports VT ablation for refractory RV VT with severe RV dysfunction.
Case Report (n=1)
This case report provides the first evidence for the feasibility of using a percutaneous right ventricular assist device to support ventricular tachycardia ablation in a patient with severe right ventricular dysfunction.
Hypothesis-generating for pRVAD-supported ablation in refractory RV VT with severe RV dysfunction; prospective validation required before clinical adoption.
Catheter ablation is an established therapy for the management of ventricular tachycardia (VT) but can be complicated by hemodynamic decompensation. Left ventricular assist devices (LVADs) have been used to support VT ablation. Percutaneous right ventricular assist devices (pRVADs) are a recent addition to the therapeutic armamentarium for the treatment of patients with right ventricular (RV) failure and there is no published literature for their use during VT ablation. Here, we present a first report of a patient treated with pRVAD-supported ablation for refractory RV VT in the setting of severe RV dysfunction.
No takes yet. Share an insight, caveat, or question.
Aguilar et al. (2019) conducted a case report in Refractory right ventricular ventricular tachycardia with severe right ventricular dysfunction (n=1). Percutaneous right ventricular assist device (pRVAD)-supported ventricular tachycardia ablation was evaluated. Percutaneous right ventricular assist device (pRVAD) was successfully used to support ventricular tachycardia ablation in a patient with refractory RV VT and severe RV dysfunction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: